UNSPSC 51392303: Medorinone

This classification denotes a phosphodiesterase inhibitor with the molecular formula C9H8N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 80X61Y4X0B, chemically known as 1,6-naphthyridin-2(1h)-one, 5-methyl- but generally known as medorinone, which bears US NIH Compound Identifier 5362132. European Medicines Agency schedules Medorinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08694MIG.

UNSPSC 51392303 Medorinone is a Commodity code that in recent state and local solicitations captures procurement of naloxone, drug deactivation systems, and related pharmaceutical products and services for community health and emergency response. The code sees activity from county health departments and state health agencies seeking to acquire these products through competitive bidding and information-gathering phases. Scope includes annual bulk purchasing of naloxone units and complementary drug management systems with quarterly delivery requirements, as well as direct-to-manufacturer pharmacy initiatives designed to improve prescription fulfillment efficiency and cost management outside traditional pharmacy benefit manager channels.

Recent activity appears concentrated in the Southeast and Texas. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023, response deadline and a two-year initial term plus one-year renewal option; the procurement required electronic bidding through the county e-procurement portal and included FEMA compliance obligations. The Texas Health and Human Services Commission issued an RFI (HHS0017013) posted April 3, 2026, to gather vendor capabilities regarding direct-to-manufacturer prescription programs for self-insured health plans and state agencies, signaling early-stage state-level interest in restructuring pharmaceutical procurement outside traditional GPO and wholesaler relationships. Neither solicitation specified set-aside designations for disadvantaged enterprises.